CNMD * Stock Overview
A medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
CONMED Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1,454.00 |
| 52 Week High | US$1,454.00 |
| 52 Week Low | US$1,179.00 |
| Beta | 1.46 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -22.82% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -12.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| CNMD * | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | -22.8% | 0% | 0% |
Return vs Industry: CNMD * underperformed the MX Medical Equipment industry which returned 16.7% over the past year.
Return vs Market: CNMD * underperformed the MX Market which returned -2.7% over the past year.
Price Volatility
| CNMD * volatility | |
|---|---|
| CNMD * Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: CNMD *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine CNMD *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 4,000 | Curt Hartman | www.conmed.com |
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands.
CONMED Corporation Fundamentals Summary
| CNMD * fundamental statistics | |
|---|---|
| Market cap | Mex$44.79b |
| Earnings (TTM) | Mex$2.68b |
| Revenue (TTM) | Mex$26.24b |
16.7x
P/E Ratio1.7x
P/S RatioIs CNMD * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNMD * income statement (TTM) | |
|---|---|
| Revenue | US$1.29b |
| Cost of Revenue | US$569.15m |
| Gross Profit | US$718.96m |
| Other Expenses | US$587.22m |
| Earnings | US$131.74m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.26 |
| Gross Margin | 55.82% |
| Net Profit Margin | 10.23% |
| Debt/Equity Ratio | 100.6% |
How did CNMD * perform over the long term?
See historical performance and comparison